在慢性鼻炎与鼻息肉中,早期与延迟的鼻手术后的喘结果
Jamie R Oliver1, Christopher L Crafton2, Easton W Attwood1
1Department of Otolaryngology-Head and Neck Surgery, Kansas University Medical Center, Kansas City, Kansas, USA.
International forum of allergy & rhinology
|December 30, 2025
概括
早期内镜外科手术治疗带有鼻息肉的慢性鼻炎可能会改善喘的结果. 接受早期手术的患者出现了较少的喘恶化,并减少了对长效β2激动剂和生物制剂的需求.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 具有鼻息肉的慢性鼻炎 (CRSwNP) 经常与喘同时发生.
- 透视鼻手术 (ESS) 可以缓解喘症状,但最佳时间仍在争论中.
- 早期 (<6个月) 与晚期 (1-3年) ESS 对喘进展的影响尚不清楚.
研究的目的:
- 调查早期ESS和改善喘结果之间的关联.
- 为了比较喘严重程度,恶化和药物使用后早期与晚期ESS.
- 为了确定早期手术干预是否会改变CRSwNP患者的长期喘轨迹.
主要方法:
- 使用TriNetX研究网络进行的回顾性队列研究.
- 接受ESS的成年CRSwNP患者被分为早期 (≤6个月) 或晚期 (1-3年) 手术组.
- 倾向性得分匹配 (1:1) 在人口统计学,基线喘严重程度和药物使用方面平衡小组,并进行5年结果分析.
主要成果:
- 早期的ESS与中度和重度持久性喘风险降低有关.
- 接受早期手术的患者出现了较少的喘恶化.
- 早期的ESS与长效β2-激动剂 (LABAs),皮质类固醇和生物药物的利用率下降有关.
结论:
- 在CRSwNP患者中,早期的ESS与更好的喘控制和减少疾病进展有关.
- 及时的外科干预可能会改变CRSwNP患者喘的自然过程.
- 早期的ESS可能会降低CRSwNP患者的长期喘治疗负担.
相关概念视频
Asthma-III: Symptoms and Complications
3.2K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.2K
Epistaxis
489
Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
489
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Suctioning the Nasopharyngeal Airway
2.7K
Nasopharyngeal suctioning is a procedure to remove secretions from the upper part of the respiratory tract that the patient cannot clear independently. It helps maintain airway patency and prevents complications such as aspiration pneumonia.
Equipment Required
Equipment Required
2.7K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K


